David J. Gregory

David J. Gregory

Auto-generated profile, based on publicly available information

David J. Gregory

Department of Pediatrics, Massachusetts General Hospital

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Clinical Microbiology Reviews
Verified
Journal Article
Closed access
PDF file
MOMartin Olivier
Martin Olivier
DGDavid J. Gregory
David J. Gregory
GFGeneviève Forget
Geneviève Forget
SUMMARY: The obligate intracellular parasiteLeishmaniamust survive the antimicrobial activities of its host cell, the macrophage, and prevent activation of an effective immune response. In order to do this, it has developed numerous highly successful strategies for manipulating activities, including antigen presentation, nitric oxide and oxygen radical generation, and cytokine production. This is generally the result of interactions betweenLeishmaniacell surface molecules, particularly gp63 and LPG, and less well identified macrophage surface receptors, causing the distortion of specific intracellular signaling cascades. We describe some of the signaling pathways and intermediates that are repressed in infected cells, including JAK/STAT, Ca2+-dependent protein kinase C (PKC) isoforms, and mitogen-activated protein kinases (especially ERK1/2), and proteasome-mediated transcription factor degradation. We also discuss protein tyrosine phosphatases (particularly SHP-1), intracellular Ca2+, Ca2+-independent PKC, ceramide, and the suppressors of cytokine signaling family of repressors, which are all reported to be activated following infection, and the role of parasite-secreted cysteine proteases.

20 January 2005 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GBGaynor J Bates
Gaynor J Bates
SNSamantha M Nicol
Samantha M Nicol
BWBrian J Wilson
Brian J Wilson
AJAnne‐Marie F Jacobs
Anne‐Marie F Jacobs
Jean-Christophe BourdonJean-Christophe Bourdon
Jean-Christophe Bourdon
FFFrances V Fuller‐Pace
Frances V Fuller‐Pace
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

6 August 2004 in BMC Molecular Biology
Verified
Journal Article
Open access
PDF file
BWBrian J Wilson
Brian J Wilson
GBGaynor J Bates
Gaynor J Bates
SNSamantha M Nicol
Samantha M Nicol
DGDavid J Gregory
David J Gregory
NPNeil D Perkins
Neil D Perkins
FFFrances V Fuller-Pace
Frances V Fuller-Pace
Background: p68 (Ddx5) and p72 (Ddx17) are highly related members of the DEAD box family and are established RNA helicases. They have been implicated in growth regulation and have been shown to be involved in both pre-mRNA and pre-rRNA processing. More recently, however, these proteins have been reported to act as transcriptional co-activators for estrogen-receptor alpha (ERα). Furthermore these proteins were shown to interact with co-activators p300/CBP and the RNA polymerase II holoenzyme. Taken together these reports suggest a role for p68 and p72 in transcriptional activation. Results: In this report we show that p68 and p72 can, in some contexts, act as transcriptional repressors. Targeting of p68 or p72 to constitutive promoters leads to repression of transcription; this repression is promoter-specific. Moreover both p68 and p72 associate with histone deacetylase 1 (HDAC1), a well-established transcriptional repression protein. Conclusions: It is therefore clear that p68 and p72 are important transcriptional regulators, functioning as co-activators and/or co-repressors depending on the context of the promoter and the transcriptional complex in which they exist.

1 March 2005 in Parasitology
Verified
Journal Article
Closed access
DGD. J. Gregory
D. J. Gregory
MOM. Olivier
M. Olivier
The protozoaLeishmaniaspp. are obligate intracellular parasites that inhabit the macrophages of their host. Since macrophages are specialized for the identification and destruction of invading pathogens, both directly and by triggering an innate immune response,Leishmaniahave evolved a number of mechanisms for suppressing some critical macrophage activities. In this review, we discuss how various species ofLeishmaniadistort the host macrophage's own signalling pathways to repress the expression of various cytokines and microbicidal molecules (nitric oxide and reactive oxygen species), and antigen presentation. In particular, we describe how MAP Kinase and JAK/STAT cascades are repressed, and intracellular Ca2+and the activities of protein tyrosine phosphatases, in particular SHP-1, are elevated.

7 April 2008 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
DGDavid J. Gregory
David J. Gregory
MGMarianne Godbout
Marianne Godbout
ICIrazú Contreras
Irazú Contreras
GFGeneviève Forget
Geneviève Forget
MOMartin Olivier
Martin Olivier
Leishmania spp. are obligate intracellular parasites that inhabit the phagolysosomes of macrophages. Manipulation of host cell signaling pathways and gene expression by Leishmania is critical for Leishmania’s survival and resultant pathology. Here, we show that infection of macrophages with Leishmania promastigotes in vitro causes specific cleavage of the NF‐κB p65RelA subunit. Cleavage occurs in the cytoplasm and is dependent on the Leishmania protease gp63. The resulting fragment, p35RelA, migrates to the nucleus, where it binds DNA as a heterodimer with NF‐κB p50. Importantly, induction of chemokine gene expression (MIP‐2/CXCL2, MCP‐1/CCL2, MIP‐1α/CCL3, MIP‐1β/CCL4) by Leishmania is NF‐κB dependent, which implies that p35RelA/p50 dimers are able to activate transcription, despite the absence of a recognized transcriptional transactivation domain. NF‐κB cleavage was observed following infection with a range of pathogenic species, including L. donovani, L. major, L. mexicana, and L. (Viannia) braziliensis, but not the non‐pathogenic L. tarentolae or treatment with IFN‐γ. These results indicate a novel mechanism by which a pathogen can subvert a macrophage's regulatory pathways to alter NF‐κB activity.

1 November 2006 in Infection and Immunity
Verified
Journal Article
Closed access
GFGeneviève Forget
Geneviève Forget
DGDavid J. Gregory
David J. Gregory
LWLorie A. Whitcombe
Lorie A. Whitcombe
MOMartin Olivier
Martin Olivier
In order to survive within the macrophages of its host organism, the protozoan parasiteLeishmaniainhibits a number of critical, gamma interferon (IFN-γ)-inducible, macrophage functions, including the generation of nitric oxide. We have previously shown that the protein tyrosine phosphatase SHP-1 (Src-homology 2 domain containing phosphatase-1) is activated duringLeishmaniainfection and plays an important role in both the survival ofLeishmaniawithin cultured macrophages and disease progression in vivo by inhibiting nitric oxide production. Here we use a SHP-1−/−macrophage cell line derived frommotheatenmice to address the mechanisms by which SHP-1 prevents IFN-γ-dependent nitric oxide production duringLeishmania donovaniinfection. We show thatLeishmaniainhibits nitric oxide production in response to IFN-γ poorly in SHP-1-deficient macrophages. This correlates with the inability ofLeishmaniato alter JAK2 and mitogen-activated protein kinase extracellular signal-regulated kinase 1 and 2 (ERK1/2) phosphorylation and to prevent nuclear translocation of transcription factors NF-κB and AP-1, although the latter two to a lesser extent. Surprisingly,Leishmaniainactivated the transcription factor STAT1 to a similar extent in SHP-1-deficient and wild-type macrophages, so STAT1 is not necessary for nitric oxide production by infected macrophages. Overall, this study demonstrates that induction of SHP-1 byLeishmaniais vital for inhibition of nitric oxide generation and that this inhibition occurs through the inactivation of JAK2 and ERK1/2, and transcription factors NF-κB and AP-1.